Serum Lactate Concentration on Admission to Hospital Predicts the Postoperative Mortality of Elderly Patients with Hip Fractures 30 Days After Surgery
Overview
Affiliations
Purpose: To determine whether serum lactate concentration on admission to hospital is a predictor for 30-day and 1-year mortality for patients who underwent hip-surgery.
Methods: Data from elderly patients with hip fractures admitted to our hospital (Jan 2012-Dec 2016) were reviewed. The lactate concentration on admission was assessed using a cut-off value of 2.0 mmol/L and then a new cut-off value was determined by maximizing the Youden index. Multivariate logistic regression was employed to verify whether a higher lactate concentration compared with the cutoff value was an independent risk factor for postoperative mortality after 30 days or at 1 year.
Results: A total of 1,004 patients were enrolled. There were differences in the incidence of postoperative complications (28.6% 21.9%, =0.022), length of stay (13.56±8.66 12.47±7.81 days, =0.047), 30-day mortality (10.8% 1.3%, <0.001), 1-year mortality (23.3% 11.8%, <0.001) and survival time (23.92±16.58 28.81±16.54 months, <0.001) between the ≥2.0 mmol/L (n=315) and <2 mmol/L (n=689) groups. Serum lactate concentration was a good predictor of 30-day mortality (AUC=0.829, <0.001) with a cutoff value of lactate =2.35 mmol/L (sensitivity =0.744, specificity =0.834). Multivariate analysis revealed that a serum lactate concentration ≥2.35 mmol/L at admission was an independent risk factor for 30-day (OR=9.93, <0.001) and 1-year (OR=2.23, <0.001) mortality.
Conclusion: The admission lactate concentration (≥2.35 mmol/L) following hip fracture derived by this study was a significant predictor of mortality 30 days after surgery, which might help physicians to stratify the risk for these patients.
Ozen Olcay H, Emektar E, Saral Ozturk Z, Akkan S, Cevik Y Ann Geriatr Med Res. 2024; 28(3):301-306.
PMID: 38952335 PMC: 11467522. DOI: 10.4235/agmr.24.0011.
McLeod G, Kennedy I, Simpson E, Joss J, Goldmann K Interact J Med Res. 2022; 11(1):e34096.
PMID: 35238320 PMC: 9008534. DOI: 10.2196/34096.